Biofrontera AG
Biofrontera AG (BFFTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BFFTF · as of Jun 8, 2026
Key Statistics
Explore Biofrontera AG Data
bfftf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
bfftf competitorsBFFTF
ATHJF
GRAMF
HMPSF
NXTTF
PCHMStock Performance
Full HistoryAbout Biofrontera AG
Biofrontera AG a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild …
what is biofrontera ag · bfftf stock overview · biofrontera ag company profile · who is biofrontera ag ceo · bfftf OTC · biofrontera ag headquarters · biofrontera ag business segments
About Stock Overview & Key Data
Biofrontera AG (BFFTF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 24, 2018. As of the latest trading session, BFFTF stock price is $0.33, with a market capitalization of $19.3M. The stock has returned -75.56% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Biofrontera AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Biofrontera AG reported revenue of $34.1M and net income of -$20.1M. For detailed data — including Biofrontera AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biofrontera AG (BFFTF) stock price is $0.33. The stock is traded on OTC under the ticker symbol BFFTF. The 52-week range is $0.33 – $22.68.